{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:19:31Z","timestamp":1791425971862,"version":"4.3.3"},"reference-count":21,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biologicals"],"published-print":{"date-parts":[[2013,7]]},"DOI":"10.1016\/j.biologicals.2013.04.005","type":"journal-article","created":{"date-parts":[[2013,6,10]],"date-time":"2013-06-10T20:01:16Z","timestamp":1370894476000},"page":"238-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril\u2122 seed lots and RK 168-73 strain"],"prefix":"10.1016","volume":"41","author":[{"given":"Jean-Claude","family":"Moulin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00e9my","family":"Silvano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V\u00e9ronique","family":"Barban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrice","family":"Riou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Allain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biologicals.2013.04.005_bib1","series-title":"Recommendations to assure the quality, safety and efficacy of live attenuated yellow fever vaccines. Proposed replacement of: TRS 872. Annex 2 and Amendment to TRS 872, Annex 2, WHO Technical Report Series No.964 (ECBS 2008); ECBS paper WHO\/BS\/10.2131","year":"2013"},{"key":"10.1016\/j.biologicals.2013.04.005_bib2","article-title":"Requirements for yellow fever vaccine (requirements for biological substances no.3 revised 1995). Annex","volume":"vol. 2","year":"1998"},{"key":"10.1016\/j.biologicals.2013.04.005_bib3","series-title":"Yellow fever vaccine (live). European Pharmacopoeia","year":"2010"},{"key":"10.1016\/j.biologicals.2013.04.005_bib4","series-title":"Yellow fever vaccine (live). European Pharmacopoeia","year":"2012"},{"key":"10.1016\/j.biologicals.2013.04.005_bib5","article-title":"Production and testing of the WHO yellow fever primary seed lot 213-77 and reference batch 168-73. Annex","volume":"vol. 6","year":"1987"},{"key":"10.1016\/j.biologicals.2013.04.005_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.biologicals.2011.04.001","article-title":"Neurovirulence tests of three 17D yellow fever vaccine strains","author":"Minor","year":"2011","journal-title":"Biologicals"},{"issue":"3","key":"10.1016\/j.biologicals.2013.04.005_bib7","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.biologicals.2005.08.005","article-title":"IABs Scientific Workshop on Neurovirulence Tests for Live Virus Vaccines","volume":"34","year":"2006","journal-title":"Biologicals"},{"issue":"15","key":"10.1016\/j.biologicals.2013.04.005_bib8","doi-asserted-by":"crossref","first-page":"2941","DOI":"10.1016\/j.vaccine.2006.06.082","article-title":"High stability of yellow fever 17D-204 vaccine: a 12-year retrospective analysis of large-scale production","volume":"25","author":"Barban","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.biologicals.2013.04.005_bib9","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1007\/BF01863914","article-title":"Beitrag zur kollektiven Behandlung pharmakologisher Reihenversuche","volume":"162","author":"K\u00e4rber","year":"1931","journal-title":"Arch Exp Pathol Pharmakol"},{"issue":"4","key":"10.1016\/j.biologicals.2013.04.005_bib10","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0092-1157(87)80003-3","article-title":"The monkey safety test for neurovirulence of yellow fever vaccines: the utility of quantitative clinical evaluation and histological examination","volume":"15","author":"Levenbook","year":"1987","journal-title":"J\u00a0Biol Stand"},{"key":"10.1016\/j.biologicals.2013.04.005_bib11","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0042-6822(03)00583-X","article-title":"Neurovirulence of yellow fever 17DD vaccine virus to thesus monkeys","volume":"316","author":"Marchevsky","year":"2003","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2013.04.005_bib12","first-page":"152","article-title":"Behavior of 17D yellow fever virus in rhesus monkeys. Relation to substrain, dose, and neural or extraneural inoculation","volume":"38","author":"Fox","year":"1943","journal-title":"Am J Hyg"},{"key":"10.1016\/j.biologicals.2013.04.005_bib13","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/oxfordjournals.aje.a120556","article-title":"Histological studies on monkey neurovirulence of group B arboviruses. I. Semiquantitative grading scale","volume":"82","author":"Nathanson","year":"1966","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.biologicals.2013.04.005_bib14","first-page":"227","article-title":"Biological characterization of plaque-size variants of yellow fever virus in mosquitoes and mice","volume":"32","author":"Miller","year":"1988","journal-title":"Acta Virol"},{"issue":"6","key":"10.1016\/j.biologicals.2013.04.005_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.vaccine.2011.12.057","article-title":"The phylogeny of yellow fever virus 17D vaccines","volume":"30","author":"Stock","year":"2012","journal-title":"Vaccine"},{"issue":"27\u201330","key":"10.1016\/j.biologicals.2013.04.005_bib16","doi-asserted-by":"crossref","first-page":"4317","DOI":"10.1016\/S0264-410X(03)00487-0","article-title":"Mutations which enhance the replication of dengue virus type 4 and an antigenic chimeric dengue virus type 2\/4 vaccine candidate in Vero cells","volume":"21","author":"Blaney","year":"2003","journal-title":"Vaccine"},{"issue":"3","key":"10.1016\/j.biologicals.2013.04.005_bib17","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1348-0421.2005.tb03719.x","article-title":"Molecular basis for adaptation of a chimeric dengue type-4\/Japanese encephalitis virus to Vero cells","volume":"49","author":"Tang","year":"2005","journal-title":"Microbiol Immunol"},{"issue":"1","key":"10.1016\/j.biologicals.2013.04.005_bib18","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/0042-6822(92)90745-B","article-title":"Heterogeneity in envelope protein sequence and N-linked glycosylation among yellow fever virus vaccine strains","volume":"188","author":"Post","year":"1992","journal-title":"Virology"},{"key":"10.1016\/j.biologicals.2013.04.005_bib19","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.biologicals.2004.09.003","article-title":"Collaborative study to assess the suitability of a candidate International Standard for yellow fever vaccine","volume":"32","author":"Ferguson","year":"2004","journal-title":"Biologicals"},{"key":"10.1016\/j.biologicals.2013.04.005_bib20","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1086\/320199","article-title":"Experimental yellow fever virus infection in the golden hamster (Mesocricetus auratus). I. Virologic, biochemical, and immunologic studies","volume":"183","author":"Tesh","year":"2001","journal-title":"J\u00a0Infect Dis"},{"key":"10.1016\/j.biologicals.2013.04.005_bib21","doi-asserted-by":"crossref","first-page":"e1000614","DOI":"10.1371\/journal.ppat.1000614","article-title":"A\u00a0mouse model for studying viscerotropic disease caused by yellow fever virus infection","volume":"5","author":"Meier","year":"2009","journal-title":"PLoS Pathog"}],"container-title":["Biologicals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1045105613000535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T11:25:09Z","timestamp":1539602709000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1045105613000535"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,7]]},"references-count":21,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,7]]}},"alternative-id":["S1045105613000535"],"URL":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.04.005","relation":{},"ISSN":["1045-1056"],"issn-type":[{"value":"1045-1056","type":"print"}],"subject":[],"published":{"date-parts":[[2013,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Yellow fever vaccine: Comparison of the neurovirulence of new 17D-204 Stamaril\u2122 seed lots and RK 168-73 strain","name":"articletitle","label":"Article Title"},{"value":"Biologicals","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biologicals.2013.04.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 The International Alliance for Biological Standardization. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}